iFIT Cluster of Excellence Newsletter Vol. II |
|
|
Dear members,
With our second Email Newsletter, we want to keep you up to date with all new information surrounding our “Image-Guided and Functionally Instructed Tumor Therapies” Cluster of Excellence.
If you have any comments or feedback feel free to get in touch with us: ifitoffice@med.uni-tuebingen.de With best regards,
iFIT Office Team |
|
|
| Prof. Dr. Hans-Georg Rammensee honored for lifetime achievement |
|
|
| iFIT PhD Training Program
|
|
|
| Prof. Dr. Hans-Georg Rammensee official member of the Leopoldina |
|
|
| ESMI Podcast with Prof. Dr. Bernd Pichler |
|
|
| New cancer treatments: Fighting inside the body |
|
|
| 1st International iFIT Conference 2023 |
|
|
| Student Internship at iFIT
|
|
|
| Ask a Scientist - World Cancer Day 2023
|
|
|
| Tübingen becomes main site of the NCT-SouthWest
|
|
|
| Prof. Dr. Cécile Gouttefangeas receives Apl. professorship
|
|
|
| Prof. Dr. Juliane Walz involved in DKTK Joint Funding (PreVision) |
|
|
| Prof. Dr. Ulrich Lauer receives DFG Funding for Multimodal therapy approaches for NUT carcinoma project |
|
|
|
iFIT Seminar Series with Dr. Stefani Spranger
5th of June 2023 at 12:00pm (CEST)
CRONA HS 210, Hoppe-Seyler-Straße 3 |
|
|
| iFIT Seminar Series with Dr. Anna Obenauf
26th of June 2023 at 12:30pm
Med. Klinik, großer Hörsaal, Otfried-Müller-Str. 10
|
|
|
| iFIT Lunch & Learn Session with Dr. Christian Schmees
17th of July 2023 at 12:00pm
CRONA HS 210, Hoppe-Seyler-Straße 3
|
|
|
| iFIT Seminar Series with Dr. Kerstin Haase
2nd of August 2023 at 02:00pm
CRONA HS 210, Hoppe-Seyler-Straße 3
|
|
|
| Presentation rhetoric "Appear credible, confident and convincing". 14th -15th of September 2023 from 09:30am - 04:00pm
iFIT Conference Room, Röntgenweg 11
|
|
|
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study |
Swen J, […], Schwab M "A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study." Lancet 2023 Feb 4;401(10374):347-356. 10.1016/S0140-6736(22)01841-4 IF: 202.7
|
MYC determines lineage commitment in KRAS-driven primary liver cancer development |
D' Artista L, […], Dauch D, […] Zender L “MYC determines lineage commitment in KRAS-driven primary liver cancer development.” J Hepatol. 2023 Mar 9;S0168-8278(23)00175-7
10.1016/j.jhep.2023.02.039 IF: 30
|
Advances in PET imaging of cancer |
Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial |
Flaadt T,[…], Seitz C, […], Lang P “Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial." Journal of Clinical Oncology 2023 Feb 10.1200/JCO.22.01630 IF: 50.7
|
Viral T-cell epitopes - Identification, characterization and clinical application |
Schroeder S, Nelde A, Walz JS “Viral T-cell epitopes - Identification, characterization and clinical application." Semin Immunol. 2023 Mar;66:101725. 10.1016/j.smim.2023.101725 IF: 30.6
|
First-in-Humans PET/MRI of In Vivo GD2 Expression in Osteosarcoma |
Trautwein N, Reischl G, [...], Pichler B, la Fougére C, Schwenck J “First-in-Humans PET/MRI of In Vivo GD2 Expression in Osteosarcoma." J Nucl Med. 2023 Feb;64(2):337-338. 10.2967/jnumed.122.264626. IF: 11
|
Neurovascular Uncoupling: Multimodal Imaging Delineates the Acute Effects of 3,4-Methylenedioxymethamphetamine |
Ionescu T, [...], Reischl G, Pichler B, [...] “Neurovascular Uncoupling: Multimodal Imaging Delineates the Acute Effects of 3,4-Methylenedioxymethamphetamine." J Nucl Med. 2023 Mar;64(3):466-471. 10.2967/jnumed.122.264391. IF: 11 |
|
|
PhD student (f/m/d) in Immunotherapy and Molecular Imaging |
Department of Preclinical Imaging and Radiopharmacy |
PhD student (f/m/d) in Molecular Immune Cell Imaging in Cancer |
Department of Preclinical Imaging and Radiopharmacy |
|
|
Follow us on social media
|
Legal Notice
Cluster of Excellence “Image-Guided and Functionally Instructed Tumor Therapies” (iFIT)
Röntgenweg 11
72076 Tübingen, Germany Contact:
Public Relations
Steven Pohl Mail: steven.patrick.pohl@med.uni-tuebingen.de Click here to unsubscribe
|
|
|
|
